Winton Group’s Edwards Lifesciences EW Stock Holding History

Winton Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,413	Closed	-$1.28M	–	982
2025 Q3	$1.28M	Sell	16,413 -57,665	-78%	-$4.51M	0.05%	357
2025 Q2	$5.79M	Buy	74,078 +43,197	+140%	+$3.22M	0.3%	69
2025 Q1	$2.24M	Sell	30,881 -12,746	-29%	-$912K	0.14%	169
2024 Q4	$3.23M	Buy	+43,627	New	+$3.05M	0.21%	122
2024 Q3	–	Sell	-23,590	Closed	-$2.18M	–	670
2024 Q2	$2.18M	Buy	23,590 +7,052	+43%	+$624K	0.15%	114
2024 Q1	$1.58M	Buy	+16,538	New	+$1.39M	0.11%	157
2023 Q3	–	Sell	-8,424	Closed	-$795K	–	815
2023 Q2	$795K	Sell	8,424 -7,559	-47%	-$657K	0.07%	195
2023 Q1	$1.32M	Buy	+15,983	New	+$1.26M	0.08%	345
2021 Q4	–	Sell	-14,515	Closed	-$1.64M	–	1129
2021 Q3	$1.64M	Buy	14,515 +11,605	+399%	+$1.32M	0.09%	275
2021 Q2	$301K	Sell	2,910 -3,774	-56%	-$356K	0.02%	1179
2021 Q1	$559K	Buy	6,684 +268	+4%	+$22.7K	0.03%	820
2020 Q4	$585K	Sell	6,416 -218,985	-97%	-$18.2M	0.04%	705
2020 Q3	$18M	Sell	225,401 -66,109	-23%	-$5.16M	0.58%	7
2020 Q2	$20.1M	Buy	291,510 +286,251	+5,443%	+$20.3M	0.52%	4
2020 Q1	$331K	Sell	5,259 -46,638	-90%	-$3.36M	0.01%	1147
2019 Q4	$4.04M	Sell	51,897 -71,448	-58%	-$5.58M	0.06%	551
2019 Q3	$9.04M	Buy	123,345 +106,113	+616%	+$7.45M	0.11%	227
2019 Q2	$1.06M	Buy	17,232 +5,019	+41%	+$303K	0.02%	396
2019 Q1	$779K	Sell	12,213 -2,802	-19%	-$160K	0.02%	417
2018 Q4	$767K	Buy	15,015 +33	+0.2%	+$1.67K	0.02%	376
2018 Q3	$869K	Sell	14,982 -8,919	-37%	-$436K	0.02%	432
2018 Q2	$1.16M	Sell	23,901 -9,780	-29%	-$456K	0.03%	395
2018 Q1	$1.57M	Buy	33,681 +7,119	+27%	+$309K	0.04%	378
2017 Q4	$998K	Sell	26,562 -10,470	-28%	-$384K	0.03%	409
2017 Q3	$1.35M	Buy	37,032 +3,321	+10%	+$127K	0.04%	364
2017 Q2	$1.33M	Sell	33,711 -427,347	-93%	-$15.6M	0.04%	308
2017 Q1	$14.5M	Sell	461,058 -315,216	-41%	-$9.87M	0.39%	86
2016 Q4	$24.2M	Sell	776,274 -1,275,003	-62%	-$41.3M	0.8%	29
2016 Q3	$82.4M	Sell	2,051,277 -209,649	-9%	-$7.9M	1.42%	3
2016 Q2	$75.2M	Sell	2,260,926 -210,234	-9%	-$7.19M	1.24%	4
2016 Q1	$72.7M	Sell	2,471,160 -98,052	-4%	-$2.71M	0.79%	20
2015 Q4	$67.6M	Sell	2,569,212 -2,089,758	-45%	-$54.3M	0.6%	40
2015 Q3	$110M	Sell	4,658,970 -383,196	-8%	-$9.25M	0.87%	9
2015 Q2	$120M	Sell	5,042,166 -904,158	-15%	-$20.4M	1.1%	3
2015 Q1	$141M	Buy	5,946,324 +1,781,172	+43%	+$40M	1.12%	2
2014 Q4	$88.4M	Buy	+4,165,152	New	+$83.7M	1.09%	1

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Winton Group's EW Position: Q4 2025 in Review

Winton Group sold out of Edwards Lifesciences (EW) in Q4 2025, closing a stake of 16,413 shares — an estimated $1.28M sold.

Winton Group first reported a position in EW in Q4 2014 and held it in 36 quarters. The position peaked at $141M in Q1 2015. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

Winton Group reported no remaining Edwards Lifesciences position as of Q4 2025 after selling out during the quarter.
Winton Group sold 16,413 Edwards Lifesciences shares in Q4 2025, an estimated $1.28M.
Winton Group first reported a position in Edwards Lifesciences in Q4 2014 and held it in 36 quarters.
Winton Group's Edwards Lifesciences position peaked at $141M in Q1 2015.
1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on Winton Group's 13F filing for Q4 2025, filed 11 Feb 2026.